Direct effects of manganese compounds on dopamine and its metabolite Dopac: An in vitro study

Environmental Toxicology and Pharmacology

Volumn 23, Issue 3, 2007, Pages 286-296

  Sistrunk, Shannon C ^a   Ross, Matthew K ^a   Filipov, Nikolay M ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Aminochrome; Dopamine; Manganese; MMT

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINOCHROME; CHROMIUM DERIVATIVE; DOPAMINE; MANGANESE; MANGANESE CHLORIDE; MANGANESE PHOSPHATE; MANGANESE SULFATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; IN VITRO STUDY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

RATTUS;

EID: 33847071113     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2006.11.004     Document Type: Article

References (57)

1. +3. Neurodegeneration 4 (1995) 329
2. Archibald F.S., and Tyree C. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch. Biochem. Biophys. 256 (1987) 638
3. Aschner M., Vrana K.E., and Zheng W. Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 20 (1999) 173
4. Autissier N., Rochette L., Dumas P., Beley A., Loireau A., and Bralet J. Dopamine and norepinephrine turnover in various regions of the rat brain after chronic manganese chloride administration. Toxicology 24 (1982) 175
5. Barbeau A., Inoue N., and Cloutier T. Role of manganese in dystonia. Adv. Neurol. 14 (1976) 339
6. Bemis J.C., and Seegal R.F. Polychlorinated biphenyls and methylmercury act synergistically to reduce rat brain dopamine content in vitro. Environ. Health Perspect. 107 (1999) 879
7. Bird E.D., Anton A.H., and Bullock B. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology 5 (1984) 59
8. Brenneman K.A., Cattley R.C., Ali S.F., and Dorman D.C. Manganese-induced developmental neurotoxicity in the CD rat: is oxidative damage a mechanism of action?. Neurotoxicology 20 (1999) 477
9. Brouillet E.P., Shinobu L., McGarvey U., Hochberg F., and Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 120 (1993) 89
10. Calne D.B., Chu N.S., Huang C.C., Lu C.S., and Olanow W. Manganism and idiopathic parkinsonism: similarities and differences [comment] [see comments]. Neurology 44 (1994) 1583
11. Cano G., Suarez-Roca H., and Bonilla E. Alterations of excitatory amino acid receptors in the brain of manganese-treated mice. Mol. Chem. Neuropathol. 30 (1997) 41
12. Chishti M.A., Fisher J.P., and Seegal R.F. Aroclors 1254 and 1260 reduce dopamine concentrations in rat striatal slices. Neurotoxicology 17 (1996) 653
13. Deneke S.M. Thiol-based antioxidants. Curr. Top. Cell Regul. 36 (2000) 151
14. Dobson A.W., Weber S., Dorman D.C., Lash L.K., Erikson K.M., and Aschner M. Oxidative stress is induced in the rat brain following repeated inhalation exposure to manganese sulfate. Biol. Trace Elem. Res. 93 (2003) 113
15. Donaldson J. The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8 (1987) 451
16. Donaldson J., McGregor D., and LaBella F. Manganese neurotoxicity: a model for free radical mediated neurodegeneration?. Can. J. Physiol. Pharmacol. 60 (1982) 1398
17. Dorman D.C., Struve M.F., James R.A., Marshall M.W., Parkinson C.U., and Wong B.A. Influence of particle solubility on the delivery of inhaled manganese to the rat brain: manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14-day) exposure. Toxicol. Appl. Pharmacol. 170 (2001) 79
18. Erikson K.M., Dorman D.C., Lash L.H., and Aschner M. Persistent alterations in biomarkers of oxidative stress resulting from combined in utero and neonatal manganese inhalation. Biol. Trace Elem. Res. 104 (2005) 151
19. Eriksson H., Tedroff J., Thuomas K.A., Aquilonius S.M., Hartvig P., Fasth K.J., Bjurling P., Langstrom B., Hedstrom K.G., and Heilbronn E. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch. Toxicol. 66 (1992) 403
20. Ferrari G., Yan C.Y., and Greene L.A. N-acetylcysteine (d- and l-stereoisomers) prevents apoptotic death of neuronal cells. J. Neurosci. 15 (1995) 2857
21. Filipov N.M., Lawrence D.A., and Seegal R.F. Influence of polychlorinated biphenyls and turning preference on striatal dopamine metabolism. J. Toxicol. Environ. Health A 68 (2005) 167
22. Gunter T.E., Miller L.M., Gavin C.E., Eliseev R., Salter J., Buntinas L., Alexandrov A., Hammond S., and Gunter K.K. Determination of the oxidation states of manganese in brain, liver, and heart mitochondria. J. Neurochem. 88 (2004) 266
23. HaMai D., and Bondy S.C. Oxidative basis of manganese neurotoxicity. Ann. NY Acad. Sci. 1012 (2004) 129
24. HaMai D., Campbell A., and Bondy S.C. Modulation of oxidative events by multivalent manganese complexes in brain tissue. Free Radic. Biol. Med. 31 (2001) 763
25. Hollrah D.P., and Roos J.W. The role of MMT in producing environmentally clean fuels. Int. J. Hydrocarbon Eng. 2 (1997) 38
26. Iregren A. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology 20 (1999) 315
27. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 64 (2005) 2021
28. Kitazawa M., Wagner J.R., Kirby M.L., Anantharam V., and Kanthasamy A.G. Oxidative stress and mitochondrial-mediated apoptosis in dopaminergic cells exposed to methylcyclopentadienyl manganese tricarbonyl. J. Pharmacol. Exp. Ther. 302 (2002) 26
29. Liccione J.J., and Maines M.D. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. J. Pharmacol. Exp. Ther. 247 (1988) 156
30. Lioy P.J. Air pollution emission profiles of toxic and trace elements from energy related sources: status and needs. Neurotoxicology 4 (1983) 103
31. Lloyd R.V. Mechanism of the manganese-catalyzed autoxidation of dopamine. Chem. Res. Toxicol. 8 (1995) 111
32. Loranger S., and Zayed J. Environmental contamination and human exposure to airborne total and respirable manganese in Montreal. J. Air Waste Manag. Assoc. 47 (1997) 983
33. Lynam D.R., Roos J.W., Pfeifer G.D., Fort B.F., and Pullin T.G. Environmental effects and exposures to manganese from use of methylcyclopentadienyl manganese tricarbonyl (MMT) in gasoline. Neurotoxicology 20 (1999) 145
34. Meinild A.K., Sitte H.H., and Gether U. Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J. Biol. Chem. 279 (2004) 49761
35. Mena I., Marin O., Fuenzalida S., and Cotzias G.C. Chronic manganese poisoning clinical picture and manganese turnover. Neurology 17 (1967) 128
36. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., and Osame M. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J. Neurol. Sci. 162 (1999) 102
37. Parenti M., Flauto C., Parati E., Vescovi A., and Groppetti A. Manganese neurotoxicity: effects of L-DOPA and pargyline treatments. Brain Res. 367 (1986) 8
38. Peristeris P., Clark B.D., Gatti S., Faggioni R., Mantovani A., Mengozzi M., Orencole S.F., Sironi M., and Ghezzi P. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol. 140 (1992) 390
39. Poirier J., Donaldson J., and Barbeau A. The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals. Biochem. Biophys. Res. Commun. 128 (1985) 25
40. Pomier-Layrargues G., Spahr L., and Butterworth R.F. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345 (1995) 735
41. Ressler T., Wong J., and Roos J. Manganese speciation in exhaust particulates of automobiles using MMT-containing gasoline. J. Synchrotron. Radiat. 6 (1999) 656
42. 2) on the absorption and cerebral distribution of manganese in rats. Arch. Toxicol. 71 (1997) 223
43. Rossman T.G., and Goncharova E.I. Spontaneous mutagenesis in mammalian cells is caused mainly by oxidative events and can be blocked by antioxidants and metallothionein. Mutat. Res. 402 (1998) 103
44. Roth J.A., Feng L., Walowitz J., and Browne R.W. Manganese-induced rat pheochromocytoma (PC12) cell death is independent of caspase activation. J. Neurosci. Res. 61 (2000) 162
45. Seegal R.F., Brosch K.O., and Bush B. High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma. J. Chromatogr. 377 (1986) 131
46. Sloot W.N., van der Sluijs-Gelling A.J., and Gramsbergen J.B. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus. J. Neurochem. 62 (1994) 205
47. Stredrick D.L., Stokes A.H., Worst T.J., Freeman W.M., Johnson E.A., Lash L.H., Aschner M., and Vrana K.E. Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology 25 (2004) 543
48. Suzuki Y., Mouri T., Nishiyama K., and Fujii N. Study of subacute toxicity of manganese dioxide in monkeys. Tokushima J. Exp. Med. 22 (1975) 5
49. Takeda A. Manganese action in brain function. Brain Res. Brain Res. Rev. 41 (2003) 79
50. Tapin D., Kennedy G., Lambert J., and Zayed J. Bioaccumulation and locomotor effects of manganese sulfate in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. Toxicol. Appl. Pharmacol. 211 (2006) 166
51. Tran T.T., Chowanadisai W., Crinella F.M., Chicz-DeMet A., and Lonnerdal B. Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 23 (2002) 635
52. Verity M.A. Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology 20 (1999) 489
53. Vescovi A., Facheris L., Zaffaroni A., Malanca G., and Parati E.A. Dopamine metabolism alterations in a manganese-treated pheochromocytoma cell line (PC12). Toxicology 67 (1991) 129
54. Vitarella D., Wong B.A., Moss O.R., and Dorman D.C. Pharmacokinetics of inhaled manganese phosphate in male Sprague-Dawley rats following subacute (14-day) exposure. Toxicol. Appl. Pharmacol. 163 (2000) 279
55. Wedler F.C., Denman R.B., and Roby W.G. Glutamine synthetase from ovine brain is a manganese(II) enzyme. Biochemistry 21 (1982) 6389
56. Yase Y. The pathogenesis of amyotrophic lateral sclerosis. Lancet 2 (1972) 292
57. Zheng W., Ren S., and Graziano J.H. Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res. 799 (1998) 334